🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Olanzapine-containing regimens for CINV prophylaxis may provide even better...
Status
Unknown
Location
N.N. Blokhin Cancer Research Center
Start Date
2018-05-25
Trial ID
NCT03478605
Treatments Being Tested
The goal of this clinical research study is to learn how different doses of...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2012-05
Trial ID
NCT01490060
This study will compare the safety and efficacy of a three-day oral aprepit...
Status
Completed
Location
Multiple Locations
Start Date
2011-09-13
Trial ID
NCT01362530
RATIONALE: Aprepitant, palonosetron, and dexamethasone may help lessen or p...
Status
Completed
Location
St. Josephs/Cander Hospital
Start Date
2006-06
Trial ID
NCT00381862
Chemotherapy induced nausea and vomiting (CINV) is one of the few mostly ob...
Status
Completed
Location
Dr. BRA IRCH, AIIMS
Start Date
2011-08
Trial ID
NCT01402024
Treatments Being Tested
Delayed nausea is a common problem after high dose chemotherapy for bone ma...
Status
Completed
Location
Uppsala University Hospital
Start Date
2010-05
Trial ID
NCT01101529
Treatments Being Tested
This pragmatic trial addresses the clinical gap through the generation of e...
Status
Unknown
Location
CHU Avicenne
Start Date
2018-09-19
Trial ID
NCT03831633
Treatments Being Tested
RATIONALE: Studying samples of blood in the laboratory from patients with c...
Status
Terminated
Location
OHSU Knight Cancer Institute
Start Date
2008-08
Trial ID
NCT00900068
Treatments Being Tested
The goal of this clinical research study is to learn the effect of combinin...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2008-03
Trial ID
NCT00651755
Treatments Being Tested
Patients diagnosed with malignant glioma who are receiving temozolomide wil...
Status
Completed
Location
The Preston Robert Tisch Brain Tumor Center at Duke
Start Date
2014-06-24
Trial ID
NCT01450826
Treatments Being Tested